Fidelity Investments
IRLA

Fidelity Investments’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Fidelity Investments’s Portfolio IRLA Stock Details IRLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Hold
0
– -$235 – 5537
2025
Q4 		– Hold
0
– – – 5203
2025
Q2 		– Hold
0
– -$67 – 5463
2025
Q1 		– Hold
0
– – – 5138
2024
Q2 		– Sell
-8
Closed -$1.59K – 5588
2024
Q1 		$1.59K Buy
+8
New +$1.99K ﹤0.01% 4729
2022
Q3 		– Sell
-2
Closed -$1K – 5304
2022
Q2 		$1K Sell
2
-2
-50% -$1.41K ﹤0.01% 4780
2022
Q1 		$5K Buy
+4
New +$5.44K ﹤0.01% 4444
2021
Q4 		– Sell
-10
Closed -$178K – 4823
2021
Q3 		$178K Hold
10
– – ﹤0.01% 2976
2021
Q2 		$103K Hold
10
– – ﹤0.01% 3028
2021
Q1 		$70K Hold
10
– – ﹤0.01% 2980
2020
Q4 		$54K Sell
10
-2
-17% -$17.7K ﹤0.01% 2986
2020
Q3 		$122K Sell
12
-32
-73% -$291K ﹤0.01% 2762
2020
Q2 		$410K Hold
44
– – ﹤0.01% 2530
2020
Q1 		$404K Hold
44
– – ﹤0.01% 2466
2019
Q4 		$497K Hold
44
– – ﹤0.01% 2495
2019
Q3 		$221K Sell
44
-319
-88% -$1.96M ﹤0.01% 2626
2019
Q2 		$3.08M Buy
+363
New +$2.17M ﹤0.01% 2225

Other funds holding IRLA

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Fidelity Investments's IRLA Position: Q1 2026 in Review

Fidelity Investments held its IRulya Therapeutics Inc. Common Stock (IRLA) position steady in Q1 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5537.

Fidelity Investments first reported a position in IRLA in Q2 2019 and has held it in 13 quarters since. The position peaked at $3.08M in Q2 2019. 43 funds tracked by Wall St. Rank hold IRLA as of Q1 2026.

  • Fidelity Investments held 0 shares of IRulya Therapeutics Inc. Common Stock worth $0 as of Q1 2026.
  • Fidelity Investments left its IRulya Therapeutics Inc. Common Stock share count unchanged in Q1 2026.
  • IRulya Therapeutics Inc. Common Stock made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #5537 holding.
  • Fidelity Investments first reported a position in IRulya Therapeutics Inc. Common Stock in Q2 2019 and has held it in 13 quarters since.
  • Fidelity Investments's IRulya Therapeutics Inc. Common Stock position peaked at $3.08M in Q2 2019.
  • 43 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.